USPTO Examiner VOORHIES RACHEL A - Art Unit 2923

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
29979431DISPLAY SCREEN WITH TRANSITIONAL GRAPHICAL USER INTERFACEDecember 2024February 2025Allow200NoNo
35523102Display Screen Panel with Graphical User InterfaceOctober 2024May 2025Allow610YesNo
29943327DISPLAY SCREEN WITH TRANSITIONAL GRAPHICAL USER INTERFACEMay 2024October 2024Allow500YesNo
29943318DISPLAY SCREEN WITH TRANSITIONAL GRAPHICAL USER INTERFACEMay 2024August 2024Allow300NoNo
29943341DISPLAY SCREEN WITH TRANSITIONAL GRAPHICAL USER INTERFACEMay 2024October 2024Allow500YesNo
29943333DISPLAY SCREEN WITH TRANSITIONAL GRAPHICAL USER INTERFACEMay 2024August 2024Allow300NoNo
29943340DISPLAY SCREEN WITH TRANSITIONAL GRAPHICAL USER INTERFACEMay 2024October 2024Allow500NoNo
29943315DISPLAY SCREEN WITH TRANSITIONAL GRAPHICAL USER INTERFACEMay 2024October 2024Allow500NoNo
29943324DISPLAY SCREEN WITH TRANSITIONAL GRAPHICAL USER INTERFACEMay 2024October 2024Allow500NoNo
29943317DISPLAY SCREEN WITH TRANSITIONAL GRAPHICAL USER INTERFACEMay 2024October 2024Allow500YesNo
29943343DISPLAY SCREEN WITH TRANSITIONAL GRAPHICAL USER INTERFACEMay 2024October 2024Allow500NoNo
29940839SCREEN WITH ANIMATED GRAPHIC USER INTERFACEMay 2024December 2024Allow710YesNo
29933269Display Screen Of A Biological Safety Cabinet With Graphical User InterfaceMarch 2024July 2024Allow401YesNo
29933258Display Screen Of A Biological Safety Cabinet With Graphical User InterfaceMarch 2024July 2024Allow401YesNo
29928517DISPLAY SCREEN WITH GRAPHICAL USER INTERFACEFebruary 2024June 2024Allow400NoNo
29925560DISPLAY SCREEN OR PORTION THEREOF WITH ANIMATED GRAPHICAL USER INTERFACEJanuary 2024April 2024Allow300YesNo
29925559DISPLAY SCREEN OR PORTION THEREOF WITH ANIMATED GRAPHICAL USER INTERFACEJanuary 2024April 2024Allow300YesNo
29925652Display Screen Or Portion Thereof With Graphical User InterfaceJanuary 2024February 2025Allow1300NoNo
29923315Computer Display Screen with Graphical User InterfaceDecember 2023October 2024Allow910NoNo
29922968Display Screen with Graphical User InterfaceDecember 2023March 2025Allow1400NoNo
29921405DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEDecember 2023April 2024Allow410NoNo
29921404DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEDecember 2023April 2024Allow400NoNo
29920632DISPLAY SCREEN WITH GRAPHICAL USER INTERFACEDecember 2023August 2024Allow800NoNo
29920405Display Screen Of A Biological Safety Cabinet With Graphical User InterfaceDecember 2023August 2024Allow801YesNo
29920193DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEDecember 2023December 2024Allow1200NoNo
29920196DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEDecember 2023December 2024Allow1300NoNo
29919616DISPLAY SCREEN WITH GRAPHICAL USER INTERFACEDecember 2023June 2024Allow700NoNo
29919625DISPLAY SCREEN WITH GRAPHICAL USER INTERFACEDecember 2023June 2024Allow700NoNo
29919620DISPLAY SCREEN WITH GRAPHICAL USER INTERFACEDecember 2023March 2024Allow300NoNo
29919626DISPLAY SCREEN WITH GRAPHICAL USER INTERFACEDecember 2023April 2025Allow1700NoNo
29916998DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACENovember 2023March 2024Allow400NoNo
29906713DISPLAY SCREEN OR PORTION THEREOF WITH AN ANIMATED GRAPHICAL USER INTERFACENovember 2023February 2024Allow300NoNo
29906192DISPLAY SCREEN WITH ANIMATED GRAPHICAL USER INTERFACE FOR CARD COMMUNICATIONNovember 2023December 2024Allow1310NoNo
29915450DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEOctober 2023April 2024Allow500NoNo
29915175Display Screen with Graphical User Interface WindowOctober 2023April 2025Allow1800NoNo
29905751DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEOctober 2023January 2025Allow1510NoNo
29913710Display Screen or Portion Thereof with a Transitional Graphical User Interface for a Medical DeviceOctober 2023August 2024Allow1100YesNo
29903889DISPLAY PANEL OR PORTION THEREOF WITH GRAPHICAL USER INTERFACESeptember 2023May 2024Allow810NoNo
29903883DISPLAY PANEL OR PORTION THEREOF WITH GRAPHICAL USER INTERFACESeptember 2023May 2024Allow810NoNo
29903785DISPLAY PANEL OR PORTION THEREOF WITH GRAPHICAL USER INTERFACESeptember 2023May 2024Allow810NoNo
29903775DISPLAY PANEL OR PORTION THEREOF WITH GRAPHICAL USER INTERFACESeptember 2023May 2024Allow810NoNo
29912758DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACESeptember 2023June 2024Allow901NoNo
35519277Display screen or portion thereof with animated graphical user interface for displaying market informationSeptember 2023April 2025Allow1912YesNo
29910803DISPLAY SCREEN OR PORTION THEREOF WITH ICON SETAugust 2023February 2025Allow1800NoNo
29910800Display Screen or Portion Thereof With Graphical User InterfaceAugust 2023August 2024Allow1201NoNo
29909093DISPLAY SCREEN OR PORTION THEREOF WITH ANIMATED GRAPHICAL USER INTERFACEAugust 2023December 2023Allow500NoNo
29898690ELECTRONIC DEVICE WITH MULTI-STATE GRAPHICAL USER INTERFACEJuly 2023October 2023Allow300NoNo
35519312Display screen with transitional graphical user interfaceJuly 2023December 2024Allow1220NoNo
29897977USER INTERFACES PRESENTING VISUALIZATION TOOLS FOR FINANCIAL HEALTH AND OTHER ATTRIBUTES OF COMPANIESJuly 2023January 2024Allow600NoNo
29879405Display Screen or Portion Thereof With a Graphical User InterfaceJuly 2023February 2025Allow2000NoNo
29879403Display Screen or Portion Thereof With a Graphical User InterfaceJuly 2023February 2025Allow2000NoNo
29878753DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEJune 2023February 2024Allow701NoNo
35521370Computer Screen With Graphical User InterfaceJune 2023May 2025Allow1111NoNo
29877920DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEJune 2023March 2024Allow901NoNo
29876210DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEMay 2023March 2025Allow2200YesNo
29876211DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEMay 2023March 2025Allow2200YesNo
29891275DISPLAY SCREEN OR PORTION THEREOF WITH TRANSITIONAL GRAPHICAL USER INTERFACEMay 2023October 2023Allow500NoNo
29874649DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEApril 2023September 2023Allow500NoNo
29874648DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEApril 2023September 2023Allow500NoNo
29874647DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEApril 2023September 2023Allow500NoNo
29889543DISPLAY SCREEN WITH GRAPHICAL USER INTERFACEApril 2023October 2023Allow600NoNo
29889338DISPLAY SCREEN OF A PROGRAMMED COMPUTER SYSTEM WITH GRAPHICAL USER INTERFACEApril 2023December 2024Allow2110NoNo
29889337DISPLAY SCREEN OF A PROGRAMMED COMPUTER SYSTEM WITH GRAPHICAL USER INTERFACEApril 2023December 2024Allow2110NoNo
29888370ELECTRONIC DEVICE OR PORTION THEREOF WITH ANIMATED GRAPHICAL USER INTERFACEMarch 2023June 2024Allow1410NoNo
35516964SCREEN WITH ANIMATED GRAPHIC USER INTERFACEFebruary 2023September 2024Abandon1620NoNo
29870835Electronic Device with Graphical User InterfaceFebruary 2023December 2024Allow2300NoNo
29870227Display Screen Of A Biological Safety Cabinet With Graphical User InterfaceJanuary 2023July 2023Allow600NoNo
29870218Display Screen Of A Biological Safety Cabinet With Graphical User InterfaceJanuary 2023July 2023Allow600NoNo
29870225Display Screen Of A Biological Safety Cabinet With Graphical User InterfaceJanuary 2023July 2023Allow600NoNo
29881073DISPLAY SCREEN OR PORTION THEREOF WITH A PAYDAY FORECAST GRAPHICAL USER INTERFACEDecember 2022September 2023Allow800NoNo
29863815DISPLAY SCREEN OR PORTION THEREOF WITH ANIMATED GRAPHICAL USER INTERFACEDecember 2022December 2024Allow2400NoNo
29862539DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEDecember 2022May 2023Allow500NoNo
29862357DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEDecember 2022July 2023Allow700YesNo
29861928DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEDecember 2022August 2023Allow800NoNo
29860972ELECTRONIC DEVICE WITH ANIMATED GRAPHICAL USER INTERFACENovember 2022April 2023Allow500NoNo
29860761ELECTRONIC DEVICE WITH ANIMATED GRAPHICAL USER INTERFACENovember 2022December 2024Allow2400NoNo
29860678DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACENovember 2022July 2023Allow810NoNo
29860009COMPUTER DISPLAY SCREEN WITH A GRAPHICAL USER INTERFACENovember 2022October 2024Allow2321YesNo
29859858DISPLAY SCREEN WITH GRAPHICAL USER INTERFACENovember 2022June 2024Allow1900YesNo
29867947DISPLAY SCREEN WITH GRAPHICAL USER INTERFACENovember 2022August 2024Allow2100NoNo
29867918TOUCH SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACENovember 2022May 2024Allow1800NoNo
29867826DISPLAY SCREEN WITH GRAPHICAL USER INTERFACENovember 2022October 2024Allow2301NoNo
29859087DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACENovember 2022November 2024Allow2500NoNo
29858224COMPUTER DISPLAY SCREEN WITH MODE SELECTION SCREEN INTERFACEOctober 2022September 2023Allow1110NoNo
35516957Display screen with graphical user interfaceOctober 2022June 2024Abandon1901NoNo
29857398ELECTRONIC DEVICE WITH ANIMATED GRAPHICAL USER INTERFACEOctober 2022May 2024Allow1800YesNo
29856807DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACEOctober 2022August 2024Allow2200NoNo
29856740ELECTRONIC DEVICE WITH ANIMATED GRAPHICAL USER INTERFACEOctober 2022August 2023Allow900NoNo
29855944Display screen or portion thereof with graphical user interfaceOctober 2022October 2024Allow2501NoNo
29855857DISPLAY SCREEN OR PORTION THEREOF WITH A TRANSITIONAL GRAPHICAL USER INTERFACEOctober 2022November 2024Allow2600NoNo
29855690Display Screen or Portion Thereof With Transitional Graphical User InterfaceOctober 2022June 2023Allow810NoNo
29855473Display Screen or Portion Thereof with a Graphical User InterfaceOctober 2022January 2024Allow1511YesNo
29855200DISPLAY SCREEN OR PORTION THEREOF WITH TRANSITIONAL GRAPHICAL USER INTERFACESeptember 2022October 2023Allow1200NoNo
29853745ELECTRONIC DEVICE WITH GRAPHICAL USER INTERFACESeptember 2022May 2023Allow800NoNo
29866540DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACESeptember 2022March 2023Allow601NoNo
29853446DISPLAY SCREEN OR PORTION THEREOF WITH A GRAPHICAL USER INTERFACESeptember 2022July 2024Allow2201NoNo
29853442Display Screen or Portion Thereof With Transitional IconSeptember 2022June 2023Allow910NoNo
29853408DISPLAY SCREEN OR PORTION THEREOF WITH A GRAPHICAL USER INTERFACESeptember 2022July 2024Allow2201NoNo
29853434DISPLAY SCREEN WITH TRANSITIONAL GRAPHICAL USER INTERFACESeptember 2022June 2023Allow900NoNo
29853406DISPLAY SCREEN OR PORTION THEREOF WITH A GRAPHICAL USER INTERFACESeptember 2022July 2024Allow2201NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner VOORHIES, RACHEL A..

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
0
(0.0%)
Examiner Reversed
1
(100.0%)
Reversal Percentile
97.2%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
3
Allowed After Appeal Filing
3
(100.0%)
Not Allowed After Appeal Filing
0
(0.0%)
Filing Benefit Percentile
98.5%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner VOORHIES, RACHEL A. - Prosecution Strategy Guide

Executive Summary

Examiner VOORHIES, RACHEL A. works in Art Unit 2923 and has examined 1,474 patent applications in our dataset. With an allowance rate of 98.1%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 18 months.

Allowance Patterns

Examiner VOORHIES, RACHEL A.'s allowance rate of 98.1% places them in the 94% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by VOORHIES, RACHEL A. receive 0.51 office actions before reaching final disposition. This places the examiner in the 4% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by VOORHIES, RACHEL A. is 18 months. This places the examiner in the 95% percentile for prosecution speed. Applications move through prosecution relatively quickly with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a -0.2% benefit to allowance rate for applications examined by VOORHIES, RACHEL A.. This interview benefit is in the 10% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 71.4% of applications are subsequently allowed. This success rate is in the 99% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 85.3% of cases where such amendments are filed. This entry rate is in the 97% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 97% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 61% percentile among all examiners. Of these withdrawals, 33.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 55.4% are granted (fully or in part). This grant rate is in the 70% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.1% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 36.7% of allowed cases (in the 96% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.